NMRA
USDNeumora Therapeutics Inc. Common Stock
Real-time Price
Price Chart
Key Metrics
Market Metrics
Open
$2.560
High
$2.920
Low
$2.550
Volume
1.60M
Company Fundamentals
Market Cap
480.9M
Industry
Biotechnology
Country
United States
Trading Stats
Avg Volume
1.36M
Exchange
NMS
Currency
USD
52-Week Range
Related News
Neumora Therapeutics to Participate in Upcoming Conferences in November
WATERTOWN, Mass., Nov. 03, 2025 (GLOBE NEWSWIRE) -- Neumora Therapeutics, Inc. (NASDAQ:NMRA), a clinical-stage biopharmaceutical company with a therapeutics pipeline consisting of seven programs that target novel
Needham Maintains Buy on Neumora Therapeutics, Raises Price Target to $8
Needham analyst Ami Fadia maintains Neumora Therapeutics with a Buy and raises the price target from $6 to $8.
Guggenheim Upgrades Neumora Therapeutics to Buy, Announces $14 Price Target
Guggenheim analyst Yatin Suneja upgrades Neumora Therapeutics from Neutral to Buy and announces $14 price target.
Neumora Therapeutics Announces Class-Leading Weight Loss Demonstrated with NMRA-215 in Preclinical Diet-Induced Obesity Model
NMRA-215 demonstrated class-leading weight loss of up to 19% as a monotherapy with semaglutide-like induction NMRA-215 demonstrated best-in-class weight loss of up to 26% in combination with semaglutide Class-leading
Related Stocks
Stay Updated
Set price alerts, get AI analysis updates and real-time market news.